Drug intelligence / Profile preview

DehydraTECH-colchicine

Development stage
Preclinical
Lead developer
Lexaria Bioscience
Modality
Small Molecules
Administration
Oral
01

Overview

DehydraTECH-colchicine is an investigational oral formulation of the small molecule colchicine, developed by Cannabis Delivery Sciences (a subsidiary of Lexaria Bioscience) using the proprietary DehydraTECH drug delivery platform. DehydraTECH is designed to enhance the bioavailability, speed of onset, and brain penetration of fat-soluble active pharmaceutical ingredients by bypassing first-pass liver metabolism. Colchicine, a well-established anti-inflammatory agent that inhibits tubulin polymerization, is being repurposed for antiviral applications, including HIV, hepatitis, influenza, and coronavirus (SARS-CoV-2). The formulation aims to leverage colchicine's ability to modulate the NLRP3 inflammasome and reduce systemic inflammation, which is often a driver of severe viral disease. The program is currently in the preclinical stage of development.

Other names
Colchicine
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on DehydraTECH-colchicine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DehydraTECH-colchicine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call